AARD News

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Aardvark Therapeutics, Inc. (AARD)

Rosen Law Firm Urges Aardvark Therapeutics, Inc. (NASDAQ: AARD) Stockholders to Contact the Firm for Information About Their Rights

AARD INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Aardvark Therapeutics, Inc. Investors – Holzer & Holzer, LLC Encourages Investors With Losses to Contact the Firm

Pomerantz LLP Announces The Filing of a Class Action Against Aardvark Therapeutics, Inc. – AARD

Pomerantz LLP Announces Class Action Lawsuit Against Aardvark Therapeutics, Inc. – AARD

Pomerantz LLP Announces Securities Class Action Litigation Against Aardvark Therapeutics, Inc. – AARD

AARD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026

Pomerantz LLP Announces Class Action Filing Against Aardvark Therapeutics, Inc. – AARD

Pomerantz LLP Announces Securities Class Action Lawsuit Against Aardvark Therapeutics, Inc. – AARD

Stockholder Alert: Robbins LLP Informs Investors of the Aardvark Therapeutics, Inc. (UWM) Class Action